Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Negrin

Showing results (91-100 of 260) with videos related to

Pageof 26
Sort By:
Blood|July 8, 2011
Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4+CD25+Foxp3+ regulatory T cellsHo-Jin Shin, Jeanette Baker, Dennis B Leveson-Gower, et al.
Cancer|December 15, 1996
High dose etoposide-based myeloablative therapy followed by autologous blood progenitor cell rescue in the treatment of multiple myelomaG D Long, N J Chao, W W Hu, et al.
Blood|July 1, 1994
Generation of T cells from cytokine-mobilized peripheral blood and adult bone marrow CD34+ cellsA H Galy, S Webb, D Cen, et al.
Cytotherapy|March 16, 2020
A novel antibody-cell conjugation method to enhance and characterize cytokine-induced killer cellsMatthew J Frank, Niclas Olsson, Andy Huang, et al.
Frontiers in Immunology|March 3, 2020
Indirect Impact of PD-1/PD-L1 Blockade on a Murine Model of NK Cell ExhaustionMaite Alvarez, Federico Simonetta, Jeanette Baker, et al.
Blood Advances|June 8, 2021
Activation of natural killer T cells enhances the function of regulatory T-cell therapy in suppressing murine GVHDToshihito Hirai, Po-Yu Lin, Federico Simonetta, et al.
Blood|November 11, 2006
In vivo dynamics of regulatory T-cell trafficking and survival predict effective strategies to control graft-versus-host disease following allogeneic transplantationVu H Nguyen, Robert Zeiser, Daniel L Dasilva, et al.
Blood|July 1, 1990
Maintenance treatment of patients with myelodysplastic syndromes using recombinant human granulocyte colony-stimulating factorR S Negrin, D H Haeuber, A Nagler, et al.
Blood|June 21, 2008
In vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of antitumor activityRyosei Nishimura, Jeanette Baker, Andreas Beilhack, et al.
The American Journal of Pathology|October 28, 2005
Ex vivo expanded dendritic cells home to T-cell zones of lymphoid organs and survive in vivo after allogeneic bone marrow transplantationChristoph H Schimmelpfennig, Stephan Schulz, Caroline Arber, et al.
Pageof 26

Showing results (91-100 of 260) with videos related to

Sort By:
Pageof 26
Blood|July 8, 2011
Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4+CD25+Foxp3+ regulatory T cellsHo-Jin Shin, Jeanette Baker, Dennis B Leveson-Gower, et al.
Cancer|December 15, 1996
High dose etoposide-based myeloablative therapy followed by autologous blood progenitor cell rescue in the treatment of multiple myelomaG D Long, N J Chao, W W Hu, et al.
Blood|July 1, 1994
Generation of T cells from cytokine-mobilized peripheral blood and adult bone marrow CD34+ cellsA H Galy, S Webb, D Cen, et al.
Cytotherapy|March 16, 2020
A novel antibody-cell conjugation method to enhance and characterize cytokine-induced killer cellsMatthew J Frank, Niclas Olsson, Andy Huang, et al.
Frontiers in Immunology|March 3, 2020
Indirect Impact of PD-1/PD-L1 Blockade on a Murine Model of NK Cell ExhaustionMaite Alvarez, Federico Simonetta, Jeanette Baker, et al.
Blood Advances|June 8, 2021
Activation of natural killer T cells enhances the function of regulatory T-cell therapy in suppressing murine GVHDToshihito Hirai, Po-Yu Lin, Federico Simonetta, et al.
Blood|November 11, 2006
In vivo dynamics of regulatory T-cell trafficking and survival predict effective strategies to control graft-versus-host disease following allogeneic transplantationVu H Nguyen, Robert Zeiser, Daniel L Dasilva, et al.
Blood|July 1, 1990
Maintenance treatment of patients with myelodysplastic syndromes using recombinant human granulocyte colony-stimulating factorR S Negrin, D H Haeuber, A Nagler, et al.
Blood|June 21, 2008
In vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of antitumor activityRyosei Nishimura, Jeanette Baker, Andreas Beilhack, et al.
The American Journal of Pathology|October 28, 2005
Ex vivo expanded dendritic cells home to T-cell zones of lymphoid organs and survive in vivo after allogeneic bone marrow transplantationChristoph H Schimmelpfennig, Stephan Schulz, Caroline Arber, et al.
Pageof 26